Persistence of rhinovirus RNA after asthma exacerbation in children

Clinical and Experimental Allergy

Volumn 35, Issue 5, 2005, Pages 672-678

  Kling, S ^a   Donninger, H ^a   Williams, Z ^a,b   Vermeulen, J ^c   Weinberg, E ^d   Latiff, K ^b   Ghildyal, R ^b   Bardin, Philip ^b,e  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b MONASH UNIVERSITY   (Australia)

^c Medi Clinic Constantiaberg   (South Africa)

^d RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

^e MONASH MEDICAL CENTRE   (Australia)

Author keywords

Asthma; Exacerbation; PEF; Rhinovirus

Indexed keywords

ALLERGEN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; VIRUS RNA;

ARTICLE; ASTHMA; ATOPY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; EMERGENCY WARD; HOSPITAL ADMISSION; HUMAN; MEASUREMENT; PEAK EXPIRATORY FLOW; POLYMERASE CHAIN REACTION; PREDICTION; PRICK TEST; PRIORITY JOURNAL; RHINOVIRUS; VALIDATION PROCESS;

ACUTE DISEASE; ALLERGENS; ASTHMA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; HUMANS; PEAK EXPIRATORY FLOW RATE; PICORNAVIRIDAE INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RHINOVIRUS; RNA, VIRAL; SEVERITY OF ILLNESS INDEX; SKIN TESTS; TREATMENT OUTCOME;

EID: 20044375825     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02244.x     Document Type: Article

References (24)

1. Pattemore PK, Johnston SL, Bardin PG. Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin Exp Allergy 1992; 22:325-36.
2. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Br Med J 1995; 310:1225-9.
3. Ferreira A, Williams Z, Donninger H et al. Rhinovirus is associated with severe asthma exacerbations and raised nasal interleukin-12. Respiration 2002; 69:136-42.
4. Rakes GP, Arruda E, Ingram JM et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med 1999; 159:785-90.
5. Belessis Y, Dixon S, Thomsen A et al. Risk factors for an intensive care unit admission in children with asthma. Pediatr Pulmonol 2004; 37:201-9.
6. McFadden ER Jr. Acute severe asthma. Am J Respir Crit Care Med 2003; 168:740-59.
7. Turner MO, Noertjojo K, Vedal S et al. Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med 1998; 157 (Part 1):1804-9.
8. Weir TD, Mallek N, Sandford AJ et al. beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med 1998; 158:787-91.
9. Sur S, Crotty TB, Kephart GM et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993; 148:713-9.
10. 2) and the severity of virus-induced asthma in children. Lancet 2003; 361:1939-44.
11. Papadopoulos NG, Moustaki M, Tsolia M et al. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med 2002; 165:1285-9.
12. Gern JE, Vrtis R, Grindle KA et al. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 2000; 162:2226-31.
13. Motala C, Kling S, Gie R et al. Guideline for the management of chronic asthma in children - 2000 update. Allergy Society of South Africa Working Group. S Afr Med J 2000; 90:524-8, 530, 532 passim.
14. Johnston SL, Sanderson G, Pattemore PK et al. Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol 1993; 31:111-7.
15. Donninger H, Glashoff R, Haitchi HM et al. Rhinovirus induction of the CXC chemokine epithelial-neutrophil activating peptide-78 in bronchial epithelium. J Infect Dis 2003; 187:1809-17.
16. Arruda E, Hayden FG. Detection of human rhino virus RNA in nasal washings by PCR. Mol Cell Probes 1993; 7:373-9.
17. Ghildyal R, Hogg G, Mills J et al. Detection and subgrouping of respiratory syncytial virus directly from nasopharyngeal aspirates. Clin Microb Infect 1997; 3:1-4.
18. Potter PC, Herman D, Toerien A et al. Clinical significance of aeroallergen identification in the western Cape. S Afr Med J 1991; 79:80-4.
19. Wark PA, Johnston SL, Moric I et al. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002; 19:68-75.
20. Jartti T, Lehtinen P, Vuorinen T et al. Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol 2004; 72:695-9.
21. Reddel H, Ware S, Marks G et al. Differences between asthma exacerbations and poor asthma control. Lancet 1999; 353: 364-9.
22. Green RM, Custovic A, Sanderson G et al. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. Br Med J 2002; 324:763.
23. Bardin PG, Fraenkel DJ, Sanderson G et al. Amplified rhinovirus colds in atopic subjects. Clin Exp Allergy 1994; 24: 457-64.
24. Bardin PG. Vaccination for asthma exacerbations. Intern Med J 2004; 34:358-60.